These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 31537428)
1. Low-dose intratympanic gentamicin administration for unilateral Meniere's disease using a method based on clinical symptomatology: Preliminary results. Scarpa A; Ralli M; Cassandro C; Gioacchini FM; Alicandri-Ciufelli M; Viola P; Chiarella G; de Vincentiis M; Cassandro E Am J Otolaryngol; 2019; 40(6):102289. PubMed ID: 31537428 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and preservation of hearing with low-dose gentamicin in unilateral meniere's disease: A clinical symptomatology-based study. Scarpa A; Avallone E; Carucci M; Salzano G; Chiarella G; Cassandro C; Viola P; Ricciardiello F; Ralli M; De Luca P; Salzano FA Am J Otolaryngol; 2024; 45(1):104116. PubMed ID: 37984050 [TBL] [Abstract][Full Text] [Related]
3. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease. Wu IC; Minor LB Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316 [TBL] [Abstract][Full Text] [Related]
4. [The long-term results of treatment of Ménière's disease with intratympanic injections of gentamicin]. Gawęcki W; Szyfter W; Lączkowska-Przybylska J; Szyfter-Harris J Otolaryngol Pol; 2012; 66(1):20-6. PubMed ID: 22381010 [TBL] [Abstract][Full Text] [Related]
6. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy. Minor LB Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525 [TBL] [Abstract][Full Text] [Related]
7. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection. Quaranta A; Aloisi A; De Benedittis G; Scaringi A Ann N Y Acad Sci; 1999 Nov; 884():410-24. PubMed ID: 10842610 [TBL] [Abstract][Full Text] [Related]
8. Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere's disease. Öztürk K; Ata N Am J Otolaryngol; 2019; 40(5):711-714. PubMed ID: 31262549 [TBL] [Abstract][Full Text] [Related]
9. [Small doses of gentamicin drum indoor injection treatment of intractableMénière disease clinical observation of the impact of the hearing]. Wang XY Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 30(12):942-944. PubMed ID: 29771059 [No Abstract] [Full Text] [Related]
10. Intratympanic gentamicin injection for refractory ménière's disease (MD) has potential effect in preventing contralateral MD occurrence. Wu Y; Zhou Y; Yu J; Song Z; Dai C; Wang J Acta Otolaryngol; 2021 Jul; 141(7):657-662. PubMed ID: 33950779 [TBL] [Abstract][Full Text] [Related]
11. Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial. Patel M; Agarwal K; Arshad Q; Hariri M; Rea P; Seemungal BM; Golding JF; Harcourt JP; Bronstein AM Lancet; 2016 Dec; 388(10061):2753-2762. PubMed ID: 27865535 [TBL] [Abstract][Full Text] [Related]
12. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease. Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414 [TBL] [Abstract][Full Text] [Related]
13. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing. Sam G; Chung DW; van der Hoeven R; Verweij S; Becker M Int J Clin Pharm; 2016 Aug; 38(4):780-3. PubMed ID: 27073077 [TBL] [Abstract][Full Text] [Related]
14. Long-Term Follow-Up of Intratympanic Methylprednisolone Versus Gentamicin in Patients With Unilateral Menière's Disease. Harcourt JP; Lambert A; Wong PY; Patel M; Agarwal K; Golding JF; Bronstein AM Otol Neurotol; 2019 Apr; 40(4):491-496. PubMed ID: 30870364 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy of intratympanic gentamicin and dexamethasone in the treatment of intractable Meniere's disease]. Wang QL; Guo XD; Mei XS; Li Y; Yao WJ; Yang XG Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):96-99. PubMed ID: 29871195 [No Abstract] [Full Text] [Related]
16. Intratympanic gentamicin in monolateral Meniere's disease: our experience. Bertino G; Durso D; Manfrin M; Casati L; Mira E Eur Arch Otorhinolaryngol; 2006 Mar; 263(3):271-5. PubMed ID: 16021460 [TBL] [Abstract][Full Text] [Related]
17. Change of VOR gain and pure-tone threshold after single low-dose intratympanic gentamicin injection in Meniere's disease. Lee JY; Kim MB Acta Otolaryngol; 2020 Apr; 140(4):314-318. PubMed ID: 31909683 [No Abstract] [Full Text] [Related]
18. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss. Derebery MJ; Fisher LM; Berliner K; Chung J; Green K Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498 [TBL] [Abstract][Full Text] [Related]
19. Intratympanic gentamicin treatment 'as needed' for Meniere's disease. Long-term analysis using the Kaplan-Meier method. Quaglieri S; Gatti O; Rebecchi E; Manfrin M; Tinelli C; Mira E; Benazzo M Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1443-9. PubMed ID: 23778723 [TBL] [Abstract][Full Text] [Related]
20. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing]. Akkuzu B; Ozgirgin N; Ozlüoğlu LN Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]